Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.

Published in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2018)

Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.

Keyphrases

multiple sclerosis
cell therapy
low dose
case report
emergency department
randomized controlled trial
stem cells
primary care
white matter
high dose
decision making
bone marrow